
ASCO 2020: Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS
The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol…
The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol…